NRC expected to issue Mo-99 facility license for Shine in 2021

May 13, 2020, 9:10PMNuclear News

Shine Medical Technologies, which is building a medical isotope production facility in Janesville, Wis., said on May 11 that it expects to have an operating license issued by the Nuclear Regulatory Commission by October 2021. Shine’s application seeking approval to operate the facility, which will produce isotopes including molybdenum-99, was accepted and docketed by the NRC last October. Mo-99, the precursor to technetium-99m, is used in more than 40 million medical patient procedures every year.

To continue reading, log in or create a free account!

Related Articles

Ho Nieh nominated to the NRC

August 6, 2025, 3:02PMNuclear News

President Trump recently nominated Ho Nieh for the role of commissioner at the Nuclear Regulatory Commission through the remainder of a term that will expire June 30, 2029.Nieh has been the...

The NRC’s Annie Caputo resigns

July 30, 2025, 7:46AMNuclear News

Commissioner Annie Caputo is resigning from the Nuclear Regulatory Commission, according to a statement sent out to staff on Tuesday morning. Her resignation comes one day after the U.S....

Palisades gets a key green light from NRC

July 28, 2025, 9:32AMNuclear News

The Palisades nuclear power plant has been formally transitioned from decommissioning status to holding an operating license following the completion of an extensive technical review by the...